Browse

AI giant Anthropic has already become a dominant player in technology and a household name for everyday users of artificial intelligence. Can it make drugs too?

The planned acquisition of Kartos Therapeutics would hand Ipsen a late-stage asset for myelofibrosis. Elsewhere, Sobi hit a regulatory setback and BeOne unveiled more positive Brukinsa data.

Depression, the New Jersey congressman said, “is physical, it is emotional, and until you experience it yourself, it is difficult to fully understand how powerful this illness can be.”